Snow David P. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 31, 2019
Insider Transaction Report
Form 4
Snow David P.
Chief Business Officer
Transactions
- Award
Restricted Stock Units
2019-01-30+25,000→ 25,000 total→ Common Stock (25,000 underlying) - Award
Stock Options
2019-01-30+55,000→ 55,000 totalExercise: $11.53Exp: 2029-01-30→ Common Stock (55,000 underlying)
Footnotes (5)
- [F1]The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on January 30, 2020, and the remainder vests in twelve equal quarterly installments thereafter.
- [F2]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F4]The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date.
- [F5]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.